Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (261-270 of 325) with videos related to

Pageof 33
Sort By:
Biochemical Pharmacology|September 1, 1986
The dopamine D1 receptor: partial purification of a digitonin-solubilized receptor-guanine nucleotide binding complexH B Niznik, D E Grigoriadis, N Y Otsuka, et al.
Endocrinology|August 1, 1985
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity formS R George, M Watanabe, T Di Paolo, et al.
FEBS Letters|January 19, 1999
Dopamine D2 receptor dimers in human and rat brainP Zawarynski, T Tallerico, P Seeman, et al.
The Journal of Biological Chemistry|June 25, 1986
Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptorH B Niznik, N Y Otsuka, A Dumbrille-Ross, et al.
Biochemical and Biophysical Research Communications|November 27, 1991
Transcription of a human dopamine D5 pseudogeneT Nguyen, R Sunahara, A Marchese, et al.
Journal of Medicinal Chemistry|January 1, 1992
(+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationshipN Baindur, M Tran, H B Niznik, et al.
Clinical Genetics|November 22, 2011
DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech populationD Šafka Brožková, J Laštůvková, H Štěpánková, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 25, 1985
Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonistA S Horn, P Tepper, J Van der Weide, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: dopamine D1 receptor sequence is normal, but has DNA polymorphismsK Ohara, C Ulpian, P Seeman, et al.
Molecular Pharmacology|July 1, 1988
Dopamine D1 receptors of the calf parathyroid gland: identification and characterizationH B Niznik, E L Fogel, C J Chen, et al.
Pageof 33

Showing results (261-270 of 325) with videos related to

Sort By:
Pageof 33
Biochemical Pharmacology|September 1, 1986
The dopamine D1 receptor: partial purification of a digitonin-solubilized receptor-guanine nucleotide binding complexH B Niznik, D E Grigoriadis, N Y Otsuka, et al.
Endocrinology|August 1, 1985
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity formS R George, M Watanabe, T Di Paolo, et al.
FEBS Letters|January 19, 1999
Dopamine D2 receptor dimers in human and rat brainP Zawarynski, T Tallerico, P Seeman, et al.
The Journal of Biological Chemistry|June 25, 1986
Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptorH B Niznik, N Y Otsuka, A Dumbrille-Ross, et al.
Biochemical and Biophysical Research Communications|November 27, 1991
Transcription of a human dopamine D5 pseudogeneT Nguyen, R Sunahara, A Marchese, et al.
Journal of Medicinal Chemistry|January 1, 1992
(+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationshipN Baindur, M Tran, H B Niznik, et al.
Clinical Genetics|November 22, 2011
DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech populationD Šafka Brožková, J Laštůvková, H Štěpánková, et al.
Pharmaceutisch Weekblad. Scientific Edition|October 25, 1985
Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonistA S Horn, P Tepper, J Van der Weide, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: dopamine D1 receptor sequence is normal, but has DNA polymorphismsK Ohara, C Ulpian, P Seeman, et al.
Molecular Pharmacology|July 1, 1988
Dopamine D1 receptors of the calf parathyroid gland: identification and characterizationH B Niznik, E L Fogel, C J Chen, et al.
Pageof 33